These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16919737)

  • 1. Judicially mandated naltrexone use by criminal offenders: a legal analysis.
    Bonnie RJ
    J Subst Abuse Treat; 2006 Sep; 31(2):121-7. PubMed ID: 16919737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone as a "mandate" or as a choice comments on "Judicially mandated naltrexone use by criminal offenders: a legal analysis".
    Presenza LJ
    J Subst Abuse Treat; 2006 Sep; 31(2):129-30. PubMed ID: 16919738
    [No Abstract]   [Full Text] [Related]  

  • 3. Depot naltrexone in lieu of incarceration: a behavioral analysis of coerced treatment for addicted offenders.
    Marlowe DB
    J Subst Abuse Treat; 2006 Sep; 31(2):131-9. PubMed ID: 16919739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone for probationers and parolees.
    O'Brien C; Cornish JW
    J Subst Abuse Treat; 2006 Sep; 31(2):107-11. PubMed ID: 16919734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research on naltrexone in the criminal justice system.
    Patapis NS; Nordstrom BR
    J Subst Abuse Treat; 2006 Sep; 31(2):113-5. PubMed ID: 16919735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of heroin-dependent persons with antagonists: current status.
    Renault PF
    NIDA Res Monogr; 1981; 28():11-22. PubMed ID: 6791000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
    Nunes EV; Rothenberg JL; Sullivan MA; Carpenter KM; Kleber HD
    Am J Drug Alcohol Abuse; 2006; 32(4):503-17. PubMed ID: 17127538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surprising conclusion by the SBU concerning the benefits of naltrexone in the treatment of heroin dependence].
    Heilig M
    Lakartidningen; 2002 Jan; 99(3):200-4. PubMed ID: 11838078
    [No Abstract]   [Full Text] [Related]  

  • 9. Naltrexone implants as treatment for heroin dependence: part I.
    Byrne A; Graham G; Hallinan R; Murnion B
    Addict Biol; 2005 Jun; 10(2):201; author reply 201-2. PubMed ID: 16191674
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance.
    Arnold-Reed DE; O'Neil P; Holman CD; Bulsara MK; Rodiguez C; Gawthorne G; Tait RJ; Hulse GK
    Am J Drug Alcohol Abuse; 2007; 33(5):655-64. PubMed ID: 17891658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narcotic antagonists: naltrexone progress report: foreword.
    Jaffe J
    NIDA Res Monogr; 1976 Sep; (9):v-vii. PubMed ID: 1088898
    [No Abstract]   [Full Text] [Related]  

  • 12. Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia.
    Krupitsky EM; Zvartau EE; Masalov DV; Tsoy MV; Burakov AM; Egorova VY; Didenko TY; Romanova TN; Ivanova EB; Bespalov AY; Verbitskaya EV; Neznanov NG; Grinenko AY; O'Brien CP; Woody GE
    J Subst Abuse Treat; 2006 Dec; 31(4):319-28. PubMed ID: 17084785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
    Camarasa X; Khazaal Y; Besson J; Zullino DF
    Eur Addict Res; 2007; 13(1):20-4. PubMed ID: 17172775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gender differences in the treatment of the opiate dependence with naltrexone].
    Ochoa E; Madoz-Gúrpide A; Salvador E
    Actas Esp Psiquiatr; 2008; 36(4):197-204. PubMed ID: 18461494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regarding naltrexone for probationers and parolees.
    Stancliff S
    J Subst Abuse Treat; 2007 Mar; 32(2):217-8; author reply 218-9. PubMed ID: 17306730
    [No Abstract]   [Full Text] [Related]  

  • 16. Naltrexone for opioid dependence. An additional tool for general practitioners.
    Tedeschi M
    Aust Fam Physician; 2002 Jan; 31(1):18-20. PubMed ID: 11840882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming opioid blockade from depot naltrexone (Prodetoxon).
    Kruptisky EM; Burakov AM; Tsoy MV; Egorova VY; Slavina TY; Grinenko AY; Zvartau EE; Woody GE
    Addiction; 2007 Jul; 102(7):1164-5. PubMed ID: 17498182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
    Hulse GK; Morris N; Arnold-Reed D; Tait RJ
    Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment.
    Tait RJ; Ngo HT; Hulse GK
    J Subst Abuse Treat; 2008 Sep; 35(2):116-24. PubMed ID: 17931824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone as negative reinforcement comments on "A behavioral analysis of coerced treatment for addicted offenders".
    Farabee D
    J Subst Abuse Treat; 2006 Sep; 31(2):141-2. PubMed ID: 16919740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.